Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Koninklijke Philips ( (PHG) ) has provided an announcement.
Royal Philips said on February 10, 2026, that it will propose the re-appointment of Roy Jakobs as President and CEO and as a member of the Board of Management at its May 8, 2026 annual general meeting. The move signals the Supervisory Board’s desire for continuity in leadership as the company pursues its next phase of profitable growth in the global health technology market.
The Supervisory Board cited progress since 2022, including addressing the Respironics recall, strengthening a culture of patient safety and quality, simplifying the organization and delivering €2.5 billion in productivity savings. It also highlighted restored growth, higher margins, positive cash generation and a stronger balance sheet, underscoring confidence that Jakobs can sustain operational improvements and long-term value creation for shareholders and other stakeholders.
The most recent analyst rating on (PHG) stock is a Hold with a $27.00 price target. To see the full list of analyst forecasts on Koninklijke Philips stock, see the PHG Stock Forecast page.
Spark’s Take on PHG Stock
According to Spark, TipRanks’ AI Analyst, PHG is a Neutral.
Koninklijke Philips faces significant financial challenges with declining revenues and net losses, impacting its valuation negatively. However, strong order intake growth and improvements in EBITDA margin and cash flow from the earnings call provide a balanced outlook. Technical indicators suggest a bearish trend, adding to the cautious sentiment.
To see Spark’s full report on PHG stock, click here.
More about Koninklijke Philips
Royal Philips (Koninklijke Philips N.V.) is a Netherlands‑based health technology company focused on improving health and well-being through patient- and people-centric innovation. It is a global leader in diagnostic imaging, ultrasound, image‑guided therapy, patient monitoring, enterprise informatics and personal health solutions for hospitals, home care and consumers, generating €18 billion in 2024 sales across more than 100 countries.
Average Trading Volume: 707,357
Technical Sentiment Signal: Buy
Current Market Cap: $28.06B
For detailed information about PHG stock, go to TipRanks’ Stock Analysis page.